These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 31901911)

  • 1. Elevated serum rheumatoid factor, anti-citrullinated protein antibodies and active rheumatoid arthritis disease are not associated with chronic periodontitis.
    Che Rahim MJ; Wan Mohamad WM; Saddki N; Taib H; Wan Abhamid WZ; Wong KK; Wan Ghazali WS
    Malays J Pathol; 2019 Dec; 41(3):267-272. PubMed ID: 31901911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients.
    Sulaiman FN; Wong KK; Ahmad WAW; Ghazali WSW
    Medicine (Baltimore); 2019 Mar; 98(12):e14945. PubMed ID: 30896663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
    Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
    Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
    Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
    Front Immunol; 2018; 9():876. PubMed ID: 29740454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
    Van Hoovels L; Jacobs J; Vander Cruyssen B; Van den Bremt S; Verschueren P; Bossuyt X
    Ann Rheum Dis; 2018 May; 77(5):667-677. PubMed ID: 29363510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IgG ACPA-IgM RF immune complexes were detected in rheumatoid arthritis patients positive for IgM ACPA.
    Haraguchi A; Yamada H; Kondo M; Okazaki K; Fukushi JI; Oyamada A; Yoshikai Y; Nakashima Y
    Clin Exp Rheumatol; 2018; 36(4):612-618. PubMed ID: 29465353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis.
    Zaccardelli A; Liu X; Ford JA; Cui J; Lu B; Chu SH; Schur PH; Speyer CB; Costenbader KH; Robinson WH; Sokolove J; Karlson EW; Camargo CA; Sparks JA
    Arthritis Res Ther; 2019 Nov; 21(1):246. PubMed ID: 31753003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive Clinical Characteristics and Outcome of ILD-Onset Rheumatoid Arthritis and ACPA-Positive ILD: a Longitudinal Cohort of 282 Cases.
    Chen RX; Zhao LD; Xiao XY; Song L; Du HY; Xu ZJ; Feng RE; Yang HX; Fei YY; Zhang W; Zhang FC; Chen H; Zhang X
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):46-54. PubMed ID: 33170478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis.
    Manca ML; Alunno A; D'Amato C; Bistoni O; Puxeddu I; Gerli R; Migliorini P; Pratesi F
    Joint Bone Spine; 2018 Jul; 85(4):441-445. PubMed ID: 28826660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis.
    Lingampalli N; Sokolove J; Lahey LJ; Edison JD; Gilliland WR; Holers VM; Deane KD; Robinson WH
    Clin Immunol; 2018 Oct; 195():119-126. PubMed ID: 29842946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and predictive value of high-positive rheumatoid factor and anti-citrullinated protein antibody levels in nonarthritic patients with chronic hepatitis C infection.
    Lin KM; Chen WM; Tung SY; Wei KL; Shen CH; Chang TS; Chang PJ
    Int J Rheum Dis; 2019 Jan; 22(1):116-120. PubMed ID: 30338656
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Hiwa R; Ikari K; Ohmura K; Nakabo S; Matsuo K; Saji H; Yurugi K; Miura Y; Maekawa T; Taniguchi A; Yamanaka H; Matsuda F; Mimori T; Terao C
    J Rheumatol; 2018 Apr; 45(4):470-480. PubMed ID: 29419463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid factor as predictor of response to treatment with anti-TNF alpha drugs in patients with rheumatoid arthritis: Results of a cohort study.
    Santos-Moreno P; Sánchez G; Castro C
    Medicine (Baltimore); 2019 Feb; 98(5):e14181. PubMed ID: 30702571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study.
    Bird P; Nicholls D; Barrett R; de Jager J; Griffiths H; Roberts L; Tymms K; McCloud P; Littlejohn G;
    Int J Rheum Dis; 2017 Apr; 20(4):460-468. PubMed ID: 28205333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of Elevations of Autoantibody Isotypes Prior to Diagnosis of Rheumatoid Arthritis.
    Kelmenson LB; Wagner BD; McNair BK; Frazer-Abel A; Demoruelle MK; Bergstedt DT; Feser ML; Moss LK; Parish MC; Mewshaw EA; Mikuls TR; Edison JD; Holers VM; Deane KD
    Arthritis Rheumatol; 2020 Feb; 72(2):251-261. PubMed ID: 31464042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.
    Schwedler C; Häupl T; Kalus U; Blanchard V; Burmester GR; Poddubnyy D; Hoppe B
    Arthritis Res Ther; 2018 Mar; 20(1):44. PubMed ID: 29540200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of anti-cyclic citrullinated peptide antibodies with clinical and radiological disease severity in rheumatoid arthritis.
    Gupta A; Kaushik R; Kaushik RM; Saini M; Kakkar R
    Curr Rheumatol Rev; 2014; 10(2):136-43. PubMed ID: 25599684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of cumulative anti-cyclic citrullinated protein antibodies with radiographic progression in patients with rheumatoid arthritis.
    Joo YB; Park YJ; Park KS; Kim KJ
    Clin Rheumatol; 2019 Sep; 38(9):2423-2432. PubMed ID: 31049760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis Still a More Severe Disease Than Anti-Citrullinated Protein Antibody-Negative Rheumatoid Arthritis? A Longitudinal Cohort Study in Rheumatoid Arthritis Patients Diagnosed From 2000 Onward.
    Boer AC; Boonen A; van der Helm van Mil AHM
    Arthritis Care Res (Hoboken); 2018 Jul; 70(7):987-996. PubMed ID: 29266813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant association of rheumatoid arthritis-related inflammatory markers with non-surgical periodontal therapy.
    Yang NY; Wang CY; Chyuan IT; Wu KJ; Tu YK; Chang CW; Hsu PN; Kuo MY; Chen YW
    J Formos Med Assoc; 2018 Nov; 117(11):1003-1010. PubMed ID: 29174174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.